Insulet PODD
NASDAQ PODD
$149.17 -2.34 (-1.54%)
At close: Aug 20, 2026 · 2:19 PM UTC

Insulet (PODD) Total Non-Current Liabilities (2010 - 2026)

Insulet's (PODD) quarterly Total Non-Current Liabilities came in at $1.6 billion in Q1 2026, down 24.19% YoY from $2.1 billion in Q1 2025, and little changed on a QoQ basis from $1.6 billion in Q4 2025.

Insulet (PODD) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Insulet (PODD) has 17 years of Total Non-Current Liabilities data on file, last reported at $1.6 billion in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 24.19% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (down 24.19% YoY) and the FY2025 annual result came in at $1.6 billion, down 11.71% from the prior year.
  • Total Non-Current Liabilities was little changed at $1.6 billion in Q1 2026, from $1.6 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.1 billion in Q1 2025 to a low of $1.6 billion in Q3 2025.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities climbed 29.78% — and 2026, when it decreased 24.19%.
  • Tracing PODD's Total Non-Current Liabilities over 5 years: stood at $1.7 billion in 2022, then increased by 4.52% to $1.8 billion in 2023, then gained by 0.37% to $1.8 billion in 2024, then declined by 11.71% to $1.6 billion in 2025, then increased by 0.38% to $1.6 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn -
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 9.07 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 3.44 Bn
10 Insulet 10.34 Bn 9.80 Bn 562.60 Mn 1.67 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.67 Bn
Mar 31, 2026 1.62 Bn
Dec 31, 2025 1.61 Bn
Sep 30, 2025 1.58 Bn
Jun 30, 2025 1.95 Bn
Mar 31, 2025 2.13 Bn
Dec 31, 2024 1.82 Bn
Sep 30, 2024 1.86 Bn
Jun 30, 2024 1.85 Bn
Mar 31, 2024 1.80 Bn
Dec 31, 2023 1.82 Bn
Sep 30, 2023 1.82 Bn
Jun 30, 2023 1.79 Bn
Mar 31, 2023 1.75 Bn
Dec 31, 2022 1.74 Bn
Sep 30, 2022 1.71 Bn
Jun 30, 2022 1.66 Bn
Mar 31, 2022 1.61 Bn
Dec 31, 2021 1.48 Bn
Sep 30, 2021 1.49 Bn